CELEBREX-A SPECIFIC INHIBITOR OF CYCLOOXIGENASE-2: EFFICACY AND TOLERABILITY

Lignende værker

• CELEBREX: THE FIRST SPECIFIC INHIBITOR OF COX-2: NEW DATA
  af: E L Nassonov
  Udgivet: (2000-08-01)
• The Cyclooxigenase-2 Inhibitor Parecoxib Prevents Epidermal Dysplasia in HPV16-Transgenic Mice: Efficacy and Safety Observations
  af: Tiago Ferreira, et al.
  Udgivet: (2019-08-01)
• The Cyclooxigenase-2 Inhibitor Parecoxib Prevents Epidermal Dysplasia in HPV16-Transgenic Mice: Efficacy and Safety Observations
  af: Ferreira, Tiago, et al.
  Udgivet: (2019)
• A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study
  af: Rogers Elaine S, et al.
  Udgivet: (2011-11-01)
• A randomised feasibility study of EPA and Cox-2 inhibitor (Celebrex) versus EPA, Cox-2 inhibitor (Celebrex), Resistance Training followed by ingestion of essential amino acids high in leucine in NSCLC cachectic patients - ACCeRT Study
  af: Rogers, Elaine S, et al.
  Udgivet: (2011)